Effect of Allopurinol on Lowering Blood Pressure in Young and Middle-age with Newly Diagnosed Essential Hypertension and Hyperuricemia

邝健,麦炜颐,黄裕立,蔡安平,江志羔,王礼春,董吁钢,吴焱贤,胡允兆

DOI: https://doi.org/10.3321/j.issn:1672-3554.2009.06.025

2009-01-01

Abstract:【Objective】 To explore therapeutic effect of Allopurinol on antihypertension in young and middle-age with hypertension and hyperuricemia.【Methods】 Randomized trial involving 60 young and middle-age with stage 1 essential hypertension and hyperuricemia,who were newly diagnosed while anti-hypertensive agent naive.Thirty cases were in allopurinol group,given the drug 200 mg three times daily in addition to a low-purine diet for 4 weeks;another 30 cases were in control group,in a low-purine diet for 4 weeks.Clinic blood pressure,ambulatory blood pressure,uric acid,hepatic and renal function,serum rennin,and angiotensinII(AngII) were measured at baseline and the end of the study.【Results】 Four weeks later,there were significant differences between two groups in decrease of clinic SBP [(7.9 ± 2.9)mmHg vs.(2.4 ± 1.5)mmHg,P 0.05],clinic DBP [(5.7 ± 2.0)mmHg vs.(2.1 ± 1.3)mmHg,P 0.05],mean ambulatory SBP [(6.8 ± 2.7)mmHg vs.(0.7 ± 1.2) mmHg,P 0.05],mean ambulatory DBP [(4.8 ± 1.3)mmHg vs.(0.5 ± 0.9)mmHg,P 0.05].More patients achieved target clinic and ambulatory BP in allopurinol group(62.1% vs.6.7% in control group,P 0.01).The decrease of serum uric acid in the allopurinol group was(85.1 ± 18.1)μmol / L [vs.(17.1 ± 9.8)μmol / L in control group,P 0.05].More patients achieved normalserum uric acid in allopurinol group(86.2% vs.16.7% in control group,P 0.05).Serum rennin and AngII decreasedsignificantly after treating with allopurinal(P 0.05 vs.control group).There was no severe adverse effect in 4 weeks treatment.Hepatic and renal function,fasting blood glucose,and lipid were not significantly different between the two groups.【Conclusion】Treating young and middle-age with hypertension and hyperuricemia with allopurinol resulted in reduction of BP.The result suggested a new potential therapeutic approach for hypertension with hyperuricemia.